Is TRDA stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Entrada Therapeutics, 10 years ago, but if you had invested on Friday 29th of October 2021 when the price was $23.95, you would have made a loss of $-9.17 per share or -38.29%
Yes, the average daily trading liquidity for Entrada Therapeutics, is $1.71 million. You should therefore be able to get in and out of your positions relatively fast.
Entrada Therapeutics, has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. Entrada Therapeutics, has a good net profit margin of 14.42% and should have high tolerances against inflation.
We have calculated the inflation risk for Entrada Therapeutics, to be medium [0.55 out of 1]